A randomized controlled trial of lumbar fusion in combination with platelet-rich plasma(PRP)
Not Applicable
- Conditions
- umbar Spinal Stenosis
- Registration Number
- JPRN-UMIN000011501
- Lead Sponsor
- Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 160
Inclusion Criteria
Not provided
Exclusion Criteria
1)Disturbance of consciousness 2)Osteoporosis(YAM<60%) 3)History of spinal surgery 4)History of tumor 5)Heart,kidney,liver and respiratoryfailure 6)Diabetes(HbA1C<7.0) 7)Smoking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
How does platelet-rich plasma (PRP) enhance spinal fusion outcomes through growth factors like TGF-β and VEGF in lumbar spinal stenosis patients?
What is the comparative effectiveness of PRP-augmented lumbar fusion versus standard decompression surgery in JPRN-UMIN000011501?
Which biomarkers predict response to PRP in lumbar spinal stenosis patients undergoing fusion surgery in the Chiba University Hospital trial?
What are the adverse event profiles and management strategies for PRP combined with lumbar fusion in JPRN-UMIN000011501?
How does PRP compare to bone morphogenetic proteins (BMPs) in promoting spinal fusion for lumbar spinal stenosis in clinical trials?